JPMORGAN CHASE & CO (JPM) SEC News Sept. 03, 2026, 13:29 UTC 0 0 comments New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-09-03 <b>AccNo:</b> 0001918704-26-026513 <b>Size:</b> 983 KB Comment Full text
NUVEEN VIRGINIA QUALITY MUNICIPAL INCOME FUND (NPV) SEC News Sept. 03, 2026, 13:28 UTC 0 0 comments New Form 3 - NUVEEN VIRGINIA QUALITY MUNICIPAL INCOME FUND <b>Filed:</b> 2026-09-03 <b>AccNo:</b> 0001225208-26-007578 <b>Size:</b> 6 KB Comment Full text
RESIDEO TECHNOLOGIES, INC. (REZI) SEC News Sept. 03, 2026, 13:25 UTC 0 1 comments HARRISON SHANE R 🟢 acquired 51.2K shares of RESIDEO TECHNOLOGIES, INC. (REZI) Transaction Date: Sep 01, 2026 | Filing ID: 000005 Comment Full text
MORGAN STANLEY (MS) SEC News Sept. 03, 2026, 13:25 UTC 0 0 comments New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-03 <b>AccNo:</b> 0001839882-26-044026 <b>Size:</b> 354 KB Comment Full text
JPMORGAN CHASE & CO (JPM) SEC News Sept. 03, 2026, 13:24 UTC 0 0 comments New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-09-03 <b>AccNo:</b> 0001918704-26-026512 <b>Size:</b> 981 KB Comment Full text
MORGAN STANLEY (MS) SEC News Sept. 03, 2026, 13:24 UTC 0 0 comments New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-03 <b>AccNo:</b> 0001839882-26-044024 <b>Size:</b> 371 KB Comment Full text
NUVEEN VIRGINIA QUALITY MUNICIPAL INCOME FUND (NPV) SEC News Sept. 03, 2026, 13:24 UTC 0 0 comments New Form 3 - NUVEEN VIRGINIA QUALITY MUNICIPAL INCOME FUND <b>Filed:</b> 2026-09-03 <b>AccNo:</b> 0001225208-26-007577 <b>Size:</b> 5 KB Comment Full text
MORGAN STANLEY (MS) SEC News Sept. 03, 2026, 13:24 UTC 0 0 comments New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-03 <b>AccNo:</b> 0001839882-26-044023 <b>Size:</b> 748 KB Comment Full text
GOLDMAN SACHS GROUP INC (GS) SEC News Sept. 03, 2026, 13:23 UTC 0 0 comments New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-09-03 <b>AccNo:</b> 0001193125-26-381426 <b>Size:</b> 118 KB Comment Full text
SUMMIT THERAPEUTICS INC. (SMMT) SEC News Sept. 03, 2026, 13:21 UTC 0 1 comments (10% Negative) SUMMIT THERAPEUTICS INC. (SMMT) Announces Delay in endpoint Development Timeline Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text